73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre

Pancreatic cancer tumor map uncovers notable differences between primary and metastatic disease

by Candace Gwaltney,Indiana UniversityIdentification of pancreatic cancer architecture. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01914-4Indiana University Melvin and Bre
Oncologists demand more education on the use of biosimilars. ESMO takes action

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ
Immunotherapy shows potential to treat deadly thyroid cancer

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o
Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H
Distinct signaling pathway identified as key driver for epithelial cancer development

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic
Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Study in mice examines impact of reused cooking oil on breast cancer progression

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i

Study in mice examines impact of reused cooking oil on breast cancer progression

by Sharita Forrest ,University of Illinois at Urbana-ChampaignThe compounds in frying oils that are repeatedly reheated to high temperatures may trigger cell proliferation and metastases i
New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent
CAR-T cell researchers optimistic about future of treating blood cancers

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl
Localized genetic mutations may serve as biomarker for wide range of cancers

Localized genetic mutations may serve as biomarker for wide range of cancers

by Melissa Rohman,Northwestern UniversityCredit: Brianna Monroe/Northwestern UniversityA team of Northwestern Medicine investigators have successfully localized novel molecular mechanisms behind

Localized genetic mutations may serve as biomarker for wide range of cancers

by Melissa Rohman,Northwestern UniversityCredit: Brianna Monroe/Northwestern UniversityA team of Northwestern Medicine investigators have successfully localized novel molecular mechanisms behind